02197

1.34010.67%
BM

Berry Michael

Chief Technical Operation Officer

Dr. Berry Michael Ph.D. also known as Mike is Chief Technical Operation Officer at Clover Biopharmaceuticals, Ltd. since March 2021. He is primarily responsible for manufacturing, supply chain, and quality of our Group. Prior to joining our Group, Dr. Berry served as a director in ARCA Bio Pharma Inc., where he was engaged in managing process development, technology transfer and scale-up and manufacturing of drug substance, from April 2005 to May 2009. From April 2010 to September 2013, he worked in Novartis Diagnostics as a director of manufacturing sciences and technology. From October 2013 to February 2015, he worked at Portola Pharmaceuticals as a senior director of bioprocess development. From February 2015 to August 2017, he worked at Dynavax Technologies as a vice president responsible for development and manufacturing sciences. Dr. Berry obtained his bachelor’s degree of science in life sciences from Leicester Polytechnic in June 1985 in the U.K., his master’s degree in chemical engineering, applied biochemistry and molecular biology of science from Victoria University of Manchester in July 1987 in the U.K., and his Ph.D. in microbiology from University of Manitoba in May 1996 in Canada.

Positions